Study of Canakinumab in Patients With Myelofibrosis
Study of Canakinumab in Patients With Myelofibrosis
Active, not recruiting · NCT05467800 · Registry updated 2026-05-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Canakinumab in Patients With Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Active, not recruiting | Phase 2 | 2026-05-07 | NCT05467800 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| John Mascarenhas | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atrium Health Levine Cancer Institute | Charlotte | United States | 14 |
| Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute | Los Angeles | United States | 5 |
| Cleveland Clinic Foundation | Cleveland | United States | 370 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| Ruttenberg Treatment Center | New York | United States | 3 |
| The University of Kansas Cancer Center-Westwood | Westwood | United States | 2 |
| Wake Forest Baptist Health Comprehensive Cancer Center | Winston-Salem | United States | 3 |